Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: April 2011

7 - Emission tomography in adult ADHD

from Section 2 - Insights into the pathophysiology of ADHD in adults


Amen DG, Carmichael BD. (1997). High-resolution brain SPECT imaging in ADHD. Ann Clin Psychiatry 9(2):81–6.
Arnsten AF, Dudley AG. (2005). Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 1(1):2.
Bechara A, Damasio H, Damasio AR. (2000). Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10(3):295–307.
Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. (2002). Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288(14):1740–8.
Castellanos FX. (2002). Proceed, with caution: SPECT cerebral blood flow studies of children and adolescents with attention deficit hyperactivity disorder. J Nucl Med 43(12):1630–3.
Castellanos FX, Tannock R. (2002). Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3(8): 617–28.
Cheon KA, Ryu YH, Kim JW, Cho DY. (2005). The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 15(1):95–101.
Cheon KA, Ryu YH, Kim YK, Namkoong K, Kim CH, Lee JD. (2003). Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging 30(2):306–11.
Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, et al. (1995). The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15(3 Pt 1):1714–23.
Conners CK. (1998). Rating scales in attention-deficit/ hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 59(suppl 7): 24–30.
Coull JT. (1998). Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog Neurobiol 55(4):343–61.
Deutsch G, Mountz JM, Katholi CR, Liu HG, Harrell LE. (1997). Regional stability of cerebral blood flow measured by repeated technetium-99m-HMPAO SPECT: implications for the study of state-dependent change. J Nucl Med 38(1):6–13.
Ding YS, Lin KS, Logan J. (2006). PET imaging of norepinephrine transporters. Curr Pharm Des 12(30):3831–45.
Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E, et al. (1995). Human and mouse dopamine transporter genes: conservation of 5’-flanking sequence elements and gene structures. Brain Res Mol Brain Res 30(2):327–35.
Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. (1999). Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354(9196):2132–3.
Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF. (2009). Variation in dopamine genes influences responsivity of the human reward system. Proc Nat Acad Sci USA 106(2):617–22.
Dresel S, Krause J, Krause KH, La Fougere C, Brinkbaumer K, Kung HF, et al. (2000). Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27(10):1518–24.
Duara R, Gross-Glenn K, Barker WW, Chang JY, Apicella A, Loewenstein D, et al. (1987). Behavioral activation and the variability of cerebral glucose metabolic measurements. J Cereb Blood Flow Metab 7(3):266–71.
Dunn BD, Dalgleish T, Lawrence AD. (2006). The somatic marker hypothesis: a critical evaluation. Neurosci Biobehav Rev 30(2):239–71.
Ernst M, Kimes AS, London ED, Matochik JA, Eldreth D, Tata S, et al. (2003). Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am J Psychiatry 160(6):1061–70.
Ernst M, Liebenauer LL, King AC, Fitzgerald GA, Cohen RM, Zametkin AJ. (1994). Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 33(6):858–68.
Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. (1998). DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 18(15):5901–7.
Ernst M, Zametkin AJ, Matochik JA, Liebenauer L, Fitzgerald GA, Cohen RM. (1994). Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings. Psychopharmacol Bull 30(2):219–25.
Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM. (1999). High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 156(8): 1209–15.
Ernst M, Zametkin AJ, Phillips RL, Cohen RM. (1998). Age-related changes in brain glucose metabolism in adults with attention-deficit/hyperactivity disorder and control subjects. J Neuropsychiatry Clin Neurosci 110(2):168–77.
Farde L, Gustavsson JP, Jonsson E. (1997). D2 dopamine receptors and personality traits. Nature 385(6617):590.
Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, et al. (1998). Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Synapse 29(2): 128–41.
Forssberg H, Fernell E, Waters S, Waters N, Tedroff J. (2006). Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav Brain Funct 2:40.
Frank MJ, Santamaria A, O’Reilly RC, Willcutt E. (2007). Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/ hyperactivity disorder. Neuropsychopharmacology 32(7):1583–99.
Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283(5400):397–401.
Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, et al. (1992). Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42(3):383–90.
Greenberg LM, Waldman ID. (1993). Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry 34:1019–30.
Hesse S, Ballaschke O, Barthel H, Sabri O. (2009). Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder. Psychiatry Res 171(2):120–8.
Hesse S, Ballaschke O, Barthel H, von Cramon DY, Sabri O. (2006). The striatal dopamine transporter availability is reduced in adults with attention-deficit/hyperactivity disorder. J Nucl Med 47(suppl 1):142.
Ilgin N, Senol S, Gucuyener K, Gokcora N, Sener S. (2001). Is increased D2 receptor availability associated with response to stimulant medication in ADHD? Dev Med Child Neurol 43(11):755–60.
Iversen LL. (1971). Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41(4):571–91.
Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. (2005). Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/ hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 57(3):229–38.
Kaya GC, Pekcanlar A, Bekis R, Ada E, Miral S, Emiroglu N, et al. (2002). Technetium-99m HMPAO brain SPECT in children with attention deficit hyperactivity disorder. Ann Nucl Med 16(8):527–31.
Kim BN, Lee JS, Cho SC, Lee DS. (2001). Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J 42(1):19–29.
Kim BN, Lee JS, Shin MS, Cho SC, Lee DS. (2002). Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder. Statistical parametric mapping analysis. Eur Arch Psychiatry Clin Neurosci 252(5):219–25.
Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. (2000). Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285(2):107–10.
Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M. (2002). Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 5(2):111–3.
Krause J, Dresel SH, Krause KH, La Fougere C, Zill P, Ackenheil M. (2006). Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry 7(3):152–7.
La Fougere C, Krause J, Krause KH, Josef Gildehaus F, Hacker M, Koch W, et al. (2006). Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder. Nucl Med Commun 27(9):733–7.
Langleben DD, Acton PD, Austin G, Elman I, Krikorian G, Monterosso JR, et al. (2002). Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. J Nucl Med 43(12):1624–9.
Larisch R, Sitte W, Antke C, Nikolaus S, Franz M, Tress W, et al. (2006). Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder. Nucl Med Commun 27(3):267–70.
Laruelle M, Kegeles LS, Abi-Dargham A. (2003). Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 1003:138–58.
Levy F, Swanson JM. (2001). Timing, space and ADHD: the dopamine theory revisited. Aust N Z J Psychiatry 35(4):504–11.
Lorberboym M, Watemberg N, Nissenkorn A, Nir B, Lerman-Sagie T. (2004). Technetium 99m ethylcysteinate dimer single-photon emission computed tomography (SPECT) during intellectual stress test in children and adolescents with pure versus comorbid attention-deficit hyperactivity disorder (ADHD). J Child Neurol 19(2):91–6.
Lou HC, Andresen J, Steinberg B, McLaughlin T, Friberg L. (1998). The striatum in a putative cerebral network activated by verbal awareness in normals and in ADHD children. Eur J Neurol 5(1):67–74.
Lou HC, Henriksen L, Bruhn P. (1984). Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 41(8):825–9.
Lou HC, Henriksen L, Bruhn P. (1990). Focal cerebral dysfunction in developmental learning disabilities. Lancet 335(8680):8–11.
Lou HC, Henriksen L, Bruhn P, Borner H, Nielsen JB. (1989). Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 46(1):48–52.
Lou HC, Rosa P, Pryds O, Karrebaek H, Lunding J, Cumming P, et al. (2004). ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow. Dev Med Child Neurol 46(3):179–83.
Ludolph AG, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck AK, et al. (2008). Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study. Neuroimage 41(3):718–27.
Madras BK, Meltzer PC, Liang AY, Elmaleh DR, Babich J, Fischman AJ. (1998). Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain. Synapse 29(2):93–104.
Matochik JA, Liebenauer LL, King AC, Szymanski HV, Cohen RM, Zametkin AJ. (1994). Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 151(5):658–64.
Matochik JA, Nordahl TE, Gross M, Semple WE, King AC, Cohen RM, et al. (1993). Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology 8(4):377–86.
McCulloch J, Kelly PAT, Ford I. (1982). Effect of apomorphine on the relationship between local cerebral glucose utilization and local berebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab 2:487–99.
Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW. (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20(6):RC65.
Murphy K, Barkley RA. (1996). Prevalence of DSM-IV ADHD symptoms in an adult community sample of licensed drivers. J Atten Disord 1:147–61.
Neve KA, Neve RL. (1997). The Dopamine Receptors. Totowa, NJ: Humana.
O’Gorman RL, Mehta MA, Asherson P, Zelaya FO, Brookes KJ, Toone BK, et al. (2008). Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: a non-invasive MRI pilot study. Neuroimage 42(1): 36–41.
Oner O, Oner P, Aysev A, Kucuk O, Ibis E. (2005). Regional cerebral blood flow in children with ADHD: changes with age. Brain Dev 27:279–85.
Pliszka SR. (2007). Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action. Neuropsychol Rev 17(1):61–72.
Potter AS, Newhouse PA. (2008). Acute nicotine improves cognitive deficits in young adults with attention-deficit/ hyperactivity disorder. Pharmacol Biochem Behav 88(4):407–17.
Raichle ME. (2006). Neuroscience. The brain's dark energy. Science 314(5803):1249–50.
Reeves SJ, Grasby PM, Howard RJ, Bantick RA, Asselin MC, Mehta MA. (2005). A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition. Neuroimage 28(1):216–26.
Reeves SJ, Mehta MA, Montgomery AJ, Amiras D, Egerton A, Howard RJ, et al. (2007). Striatal dopamine (D2) receptor availability predicts socially desirable responding. Neuroimage 34(4):1782–9.
Rosa Neto P, Lou H, Cumming P, Pryds O, Gjedde A. (2002). Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Ann N Y Acad Sci 965:434–9.
Scheres A, Milham MP, Knutson B, Castellanos FX. (2007). Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry 61(5):720–4.
Schou M, Pike VW, Halldin C. (2007). Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography. Curr Top Med Chem 7(18):1806–16.
Schweitzer JB, Faber TL, Grafton ST, Tune LE, Hoffman JM, Kilts CD. (2000). Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am J Psychiatry 157(2): 278–80.
Schweitzer JB, Lee DO, Hanford RB, Tagamets MA, Hoffman JM, Grafton ST, et al. (2003). A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response. Neuropsychopharmacology 28(5):967–73.
Schweitzer JB, Lee DO, Hanford RB, Zink CF, Ely TD, Tagamets MA, et al. (2004). Effect of methylphenidate on executive functioning in adults with attention-deficit/ hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatry 56(8): 597–606.
Seeman P, Madras BK. (1998). Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 3(5):386–96.
Seeman P, Madras B. (2002). Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 130(1–2):79–83.
Sieg KG, Gaffney GR, Preston DF, Hellings JA. (1995). SPECT brain imaging abnormalities in attention deficit hyperactivity disorder. Clin Nucl Med 20(1):55–60.
Solanto MV. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94(1):127–52.
Spencer TJ, Biederman J, Ciccone PE, Madras BK, Dougherty DD, Bonab AA, et al. (2006). PET study examining pharmacokinetics, detection and lieability, and dopamine transporter occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry 163:387–95.
Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, et al. (2007). Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry 62(9):1059–61.
Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, et al. (2005). In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 57(11):1293–300.
Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, et al. (2007). Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 17(1):39–59.
Szobot CM, Ketzer C, Cunha RD, Parente MA, Langleben DD, Acton PD, et al. (2003). The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. Eur J Nucl Med Mol Imaging 30(3):423–6.
Szobot C, Roman T, Cunha R, Acton P, Hutz M, Rohde LA. (2005). Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 132(1):53–8.
Tomer R, Goldstein RZ, Wang GJ, Wong C, Volkow ND. (2008). Incentive motivation is associated with striatal dopamine asymmetry. Biol Psychiatry 77(1): 98–101.
Tseng KY, O’Donnell P. (2007). Dopamine modulation of prefrontal cortical interneurons changes during adolescence. Cereb Cortex 17:1235–40.
Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH, et al. (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Nat Acad Science USA 95(24):14494–9.
Valera EM, Faraone SV, Biederman J, Poldrack RA, Seidman LJ. (2005). Functional neuroanatomy of working memory in adults with attention-deficit/ hyperactivity disorder. Biol Psychiatry 57(5): 439–47.
Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, et al. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14(4):1104–6.
van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, et al. (2002). Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry 159(2):309–12.
Vles JS, Feron FJ, Hendriksen JG, Jolles J, van Kroonenburgh MJ, Weber WE. (2003). Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD). Neuropediatrics 34(2):77–80.
Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS, et al. (1998). Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 155(3):344–9.
Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, et al. (1998). Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155(10): 1325–31.
Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, et al. (1997). Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154(1):50–5.
Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, et al. (2004). Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 161(7):1173–80.
Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, et al. (2009). Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302(10):1084–91.
Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, et al. (2007). Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 34(3):1182–90.
Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, et al. (2007). Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64(8):932–40.
Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, et al. (1993). Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 50(5):333–40.
Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, et al. (1990). Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 323(20):1361–6.